Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Development of Immunocompetence

Development of Immunocompetence

The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...

Transcytosis of IgG

Transcytosis of IgG

Transcytosis is the process in which molecules are internalized by endocytosis, transported across the cell, and released through exocytosis from the opposite end of the cell. Molecules such as insulin, immunoglobulins, and certain nutrients are transferred through the recycling endosomes by recycling and transcytosis.
IgG molecules from a mother undergo transcytosis starting around 13 weeks of gestation. The amount of IgG transferred and entering the fetal blood circulation increases with...

Teratogenicity

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...

Rh Blood Group

Rh Blood Group

The Rhesus (Rh) antigen is crucial in determining blood groups and ensuring compatibility during blood transfusions.

Cytomegalovirus Disease

Cytomegalovirus Disease

Cytomegalovirus (CMV) disease is caused by human cytomegalovirus, a double-stranded DNA virus of the Herpesviridae family. While primary CMV infection is often asymptomatic in immunocompetent individuals, the virus can cause severe disease in neonates and immunocompromised patients. CMV is the most common cause of congenital viral infection in the United States, and a major pathogen in solid organ and hematopoietic stem cell transplant recipients.CMV is transmitted via bodily fluids, sexual...

Nephrotic Syndrome I : Introduction

Nephrotic Syndrome I : Introduction

Nephrotic Syndrome is a chronic kidney disorder defined by clinical findings such as severe proteinuria, hypoalbuminemia, hyperlipidemia, and edema. These symptoms result from damage to the glomeruli, the kidney’s filtering units, increasing their permeability to proteins.Definition and Meaning:Proteinuria, defined as the loss of more than 3.5 grams of protein per day in adults, is a crucial feature of nephrotic syndrome. This condition is often accompanied by edema, the accumulation of fluid...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Response to the Letter to the Editor Entitled "Integrating Tissue Proteomics and Urinary Analysis to Capture Dynamic Podocyte Injury".

Kidney international reports·2026

Same author

Autoantibodies reactive with glomerular endothelial cells and podocytes in patients with membranous nephropathy.

Journal of translational autoimmunity·2026

Same author

Mass Spectrometry of Minimal Change Disease and Focal Segmental Glomerulosclerosis.

Kidney international reports·2025

Same author

Identification of early predictors of clinical remission in primary membranous nephropathy: a <i>post hoc</i> analysis of the STARMEN trial.

Clinical kidney journal·2025

Same author

Microphysiological Glomerular Filtration Barriers: Current Insights, Innovations, and Future Applications.

Advanced biology·2025

Same author

Anti-nephrin antibodies guide living donor kidney transplantation in a pediatric patient with primary focal segmental glomerular sclerosis.

Kidney international·2025

Search research articles

Related Experiment Video

Updated: Jul 11, 2026

Isolation of Leukocytes from the Murine Tissues at the Maternal-Fetal Interface

Isolation of Leukocytes from the Murine Tissues at the Maternal-Fetal Interface

Published on: May 21, 2015

Fetomaternal alloimmunization with antenatal glomerulopathies.

Hanna Debiec¹, Pierre Ronco

¹INSERM U 702, Pierre et Marie Curie University-Paris, UMRS, Ap-Hp Tenon Hospital, Paris, France. hanna.debiec@chusa.jussieu.fr

Annals of the New York Academy of Sciences

|October 4, 2007

Summary

Fetomaternal alloimmunization with antenatal glomerulopathies (FMAIG) involves maternal antibodies targeting fetal kidney cells. Identifying specific epitopes on neutral endopeptidase (NEP) is crucial for diagnosing and treating this rare condition.

More Related Videos

Intracerebroventricular and Intravascular Injection of Viral Particles and Fluorescent Microbeads into the Neonatal Brain

Intracerebroventricular and Intravascular Injection of Viral Particles and Fluorescent Microbeads into the Neonatal Brain

Published on: July 24, 2016

Related Experiment Videos

Last Updated: Jul 11, 2026

Isolation of Leukocytes from the Murine Tissues at the Maternal-Fetal Interface

Isolation of Leukocytes from the Murine Tissues at the Maternal-Fetal Interface

Published on: May 21, 2015

Intracerebroventricular and Intravascular Injection of Viral Particles and Fluorescent Microbeads into the Neonatal Brain

Intracerebroventricular and Intravascular Injection of Viral Particles and Fluorescent Microbeads into the Neonatal Brain

Published on: July 24, 2016

Area of Science:

Immunology
Nephrology
Reproductive Medicine

Background:

Fetomaternal alloimmunization with antenatal glomerulopathies (FMAIG) is a newly identified alloimmune disorder.
It arises from maternal antibodies crossing the placenta and targeting fetal glomerular podocytes, causing renal disease.
Pathogenic antibodies are directed against neutral endopeptidase (NEP), with mothers being NEP-deficient and becoming immunized during pregnancy.

Purpose of the Study:

To identify specific pathogenic epitopes on neutral endopeptidase (NEP).
To aid in the development of diagnostic tests and targeted therapies for FMAIG.
To address the high risk to fetuses in subsequent pregnancies of NEP-immunized mothers.

Main Methods:

Characterization of linear B cell epitopes on NEP.
Analysis of antibody recognition of NEP epitopes.

Main Results:

Two linear B cell epitopes on NEP were identified.
These epitopes are specifically recognized by maternal antibodies in FMAIG cases.
The findings provide a basis for diagnostic and therapeutic strategies.

Conclusions:

Identification of NEP epitopes is vital for understanding and managing FMAIG.
These epitopes can guide the development of diagnostic assays and peptide-specific immune interventions.
Further research into antigen-driven therapies, including mucosal tolerance, is warranted.